Lower GI Series
A lower GI series is a procedure in which a doctor uses x-rays and a chalky liquid called bariumt ... Read More
Liver biopsy is the biopsy (removal of a small sample of tissue) from the liver. It is a medical test that is done to aid diagnosis of liver disease, to assess the severity of known liver disease, and to monitor the progress of treatment.
Liver biopsies may be taken percutaneously (via a needle through the skin), transvenously (through the blood vessels), endoscopically (through endoscopic ultrasound fine needle biopsy), or directly during abdominal surgery. The sample is examined by microscope, and may be processed further by immunohistochemistry, determination of iron and copper content, and microbiological culture if tuberculosis is suspected.
Market Analysis and Insights: Global Liver Biopsy Market
The global Liver Biopsy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Liver Biopsy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Liver Biopsy market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Liver Biopsy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Liver Biopsy market.
Global Liver Biopsy Scope and Market Size
Liver Biopsy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Liver Biopsy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Percutaneous
Transjugular
Laparoscopic
Segment by Application
Hospitals & Clinics
Diagnostic Centers
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Cook Medical
Boston Scientific
Hologic
MDxHealth
CR Bard
Intact Medical
Veran Medical
Leica Biosystems
A lower GI series is a procedure in which a doctor uses x-rays and a chalky liquid called bariumt ... Read More
Lung cancer, also known as lung carcinoma, is a malignant lung tumor characterized by uncontrolle ... Read More
Malabsorption syndrome refers to a number of disorders in which the small intestine can’t absor ... Read More
Cancers that start anywhere in the body’s lymphatic system are called lymphomas. If they have t ... Read More